SCHEMBL4608240

SCHEMBL4608240

COc1cc(S(=O)(=O)c2ccncc2)ccc1[N+](=O)[O-]

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TXNRD1 Q16881 1/20 0.60
MAPK1 P28482 3/20 0.50
POLB P06746 2/20 0.50
TSHR P16473 1/20 0.50
ALDH1A1 P00352 6/20 0.48
LMNA P02545 1/20 0.48
KMT2A Q03164 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
MAPT P10636 3/20 0.45
S1PR4 O95977 2/20 0.45
S1PR1 P21453 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
RAB9A P51151 1/20 0.45
GFER P55789 1/20 0.45
PAX8 Q06710 1/20 0.45
HTT P42858 2/20 0.44
JAK2 O60674 1/20 0.44
HSP90AA1 P07900 1/20 0.44
SIRT6 Q8N6T7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2900568 0.85 MAPK1 (0.57) MAPK1POLBTSHRALDH1A1LMNA
SCHEMBL30184523 0.79 SMN1; SMN2 (0.54) MAPK1POLBTSHRALDH1A1LMNA
SCHEMBL6522436 0.79 SMN1; SMN2 (0.54) MAPK1POLBTSHRALDH1A1LMNA
SCHEMBL310270 0.78 CYP11B1 (0.59) POLBALDH1A1LMNAKMT2AL3MBTL1
SCHEMBL22005940 0.78 TXNRD1 (0.50) TXNRD1MAPK1POLBTSHRALDH1A1
SCHEMBL4608494 0.78 TSHR (0.54) TXNRD1MAPK1POLBTSHRALDH1A1
SCHEMBL30871423 0.77 CA2 (0.56) POLBALDH1A1LMNAKMT2AL3MBTL1
SCHEMBL15823469 0.77 ALDH1A1 (0.54) MAPK1POLBTSHRALDH1A1LMNA
SCHEMBL10911114 0.77 ALDH1A1 (0.51) TXNRD1MAPK1POLBTSHRALDH1A1
SCHEMBL15824942 0.77 ALDH1A1 (0.51) MAPK1POLBTSHRALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1059927-B1 CHEMICAL COMPOUNDS AND THEIR USE TO ELEVATE PYRUVATE DEHYDROGENASE ACTIVITY ASTRAZENECA AB (SE) 2008-07-30 EP disclosed
US-6369273-B1 ARYL ALCOHOLS OR ESTERS FOR ELEVATION OF PYRUVATE DHYDROGENASE ASTRAZENECA AB (SE) 2002-04-09 US disclosed
EP-0617010-B1 Therapeutic compounds ASTRAZENECA AB (SE) 2002-01-09 EP disclosed
EP-1059927-A1 CHEMICAL COMPOUNDS AND THEIR USE TO ELEVATE PYRUVATE DEHYDROGENASE ACTIVITY AstraZeneca AB (SE) 2000-12-20 EP disclosed
WO-1999044618-A1 CHEMICAL COMPOUNDS AND THEIR USE TO ELEVATE PYRUVATE DEHYDROGENASE ACTIVITY ASTRAZENECA AB (SE) 1999-09-10 WO disclosed
US-5900432-A Therapeutic N-(4-benzoyl-2-methyl-phenyl)-3,3,3-trifluoro-2-hydroxy-2-methyl-propanamides ZENECA LIMITED (GB) 1999-05-04 US disclosed
US-5482969-A Certain N(4-benzoyl-2-phenyl)-3- trifluoro-2-hydroxy-propanamide derivatives ZENECA LIMITED (GB) 1996-01-09 US disclosed
EP-0617010-A1 Therapeutic compounds ZENECA LIMITED (GB) 1994-09-28 EP disclosed